FDA expands indication for schizophrenia med; First FDA-approved injectable for double chin launches;

> The FDA allowed Otsuka's schizophrenia-fighting Abilify Maintena to be injected into the the deltoid muscle of the arm, giving it a second administration sight in addition to the gluteus. More

> Ocean Drive Plastic Surgery just launched the first FDA-approved injectable for double chin. More